Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2008

Jun 13, 2008

30786_dirs_2008-06-13_d3ecdde2-37f3-447d-a4af-7776d2f85ffe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO RAD LABORATORIES INC (BIO, BIO.B)
CIK: 0000012208
Period of Report: 2008-06-11

Reporting Person: SCHWARTZ NORMAN D (Director, CEO, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2008-06-11 Bio-Rad B Common Stock A 12500 Acquired 76574 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2008-06-11 Non-Qualified Stock Option (right to buy) $88.48 A 37500 Acquired 2018-06-11 Bio-Rad B Common Stock (37500) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Bio-Rad A Common Stock 211454 Direct
Bio-Rad B Common Stock 363440 Indirect
Bio-Rad B Common Stock 13726 Indirect
Bio-Rad B Common Stock 11200 Indirect

Footnotes

F1: The shares are held by a limited partnership of which the reporting person is a general partner.

F2: The shares are held by a limited partnership of which the reporting person is a limited partner.

F3: The reporting person disclaims beneficial ownership of these shares.

F4: The stock option vests over five years at 20% per year on the yearly anniversary date of the grant.